Materials that hold a negative value or that companies do not realise have any value that can be recovered will most likely be lost in the disposal process. This means every year millions of pounds worth of precious metals could be being literally poured down the drain. Read the comment article in C&I Magazine.
Just among us chemists, I’ll bet many of you have shared the ‘pariah’ experience. ‘Eew, you work with chemicals…or the chemical industry…or with plastics’ and so on, accompanied by a withering stare. Read the comment article in C&I Magazine.
Most business leaders will, at some point, need to pitch for investment. Unless you’re a scion of a rich dynasty, as your business grows you will need an injection of capital to keep moving forward.
The early 2021 cold snap in the US dramatically impacted the country’s petrochemical industry. The concentration of the winter storm was particularly pronounced in Texas, which geographically represents the workhorse of the US olefins industry, paralysing US petrochemical production and disrupting 15% of the global olefins market. Read more in C&I Magazine.
For many in non-scientific industries, it might be simple enough to carry on working with the addition of Zoom and Google Docs to keep workflows running smoothy, however, for those in scientific, evidence-based industries, where the collection, structuring and sharing of data is vital, the impact has been more complex and challenging, highlighting concerns about the long-term viability of our industry in its current state.
The UFI serves as a unique recipe identifier and helps with the exact identification of a dangerous mixture to enable faster first aid.
The UK Government has to incentivise UK scientists and business entrepreneurs by giving them a variety of tax breaks if it is meet its green agenda. The Government’s 10-point green plan is a positive step in addressing the challenges of climate change but in order to make the UK the centre of the green economy further scientific and business incentivisation is needed right now. Read more in C&I Magazine.
The UK is now facing a significant problem in how it secures the country’s medicines’ supply chain after leaving the EU on 1 January 2021. But rather than view this as an insurmountable problem, FarmaTrust is calling on the UK government to be true to its word and deliver new Brexit benefits.
Covid-19 was an unpredictable so-called black swan event in 2020 and the second wave in Europe indicates we might need to live with the pandemic for a long time. Although the development of vaccines is a breakthrough, the impact of vaccination will be slow to materialise.
Microfluidic technologies are rapidly becoming the method of choice for micro- and nanoparticle production across a number of sectors, from cell biology research to drug development. This approach offers a number of advantages over traditional batch methods, including precise process control, enhanced reliability, and the ability to easily scale up production. Read more in C&I Magazine.